UPDATE: Canaccord Genuity On Retrophin 'Sees 1H19 proof-of-concept data for CNSA-001 in PKU patients, (2) April'19 data from SONAR study of atrasentan in diabetic nephropathy, and (3) June 30 PDUFA for a new formulation of Thiola' As Catalysts In 1H19
Benzinga_Newsdesk